Literature DB >> 35182266

Comparison of combined anterior-posterior and posterior-only approaches for lumbosacral chordomas: a systematic review and meta-analysis of surgical and clinical outcomes.

Quintino Giorgio D'Alessandris1,2, Martina Offi1,2, Valerio Maria Caccavella2, Martina Giordano3, Eduardo Fernandez1,2, Liverana Lauretti1,2, Roberto Pallini1,2, Alessandro Olivi1,2, Nicola Montano1,2.   

Abstract

Lumbosacral chordoma is a slow-growing but locally aggressive tumor, resistant to adjuvant treatments and endowed with dismal prognosis. Surgery is the mainstay of treatment but the choice of surgical approach (the posterior-only approach or the combined anterior-posterior approach) remains an open question due to the need of both pursuing a surgical radicality and preserving the neurologic function. The aim of the study was to compare the surgical and clinical outcomes of these approaches in the management of lumbosacral chordomas. A systematic review and meta-analysis in agreement with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines of papers comparing the outcomes of the two approaches was performed. Ten papers met the inclusion criteria. The combined anterior-posterior approach was more frequently performed for tumors with an upper level beyond S2 (p = 0.012). The 5-year progression-free survival was significantly higher in posterior-only approach compared with the combined anterior-posterior approach (44.7% vs 27.1%, p = 0.049). Adjuvant radiotherapy was added more frequently after a posterior-only approach (p = 0.036) and the rate of complications was significantly lower after a posterior-only approach (p = 0.040). No significant differences in sex, age, tumor diameter, entity of resection, and overall survival were observed. Posterior-only surgical approach may be a reasonable option for lumbosacral chordoma, being associated with comparable entity of surgical resection, reduced complication rate and increased 5-year progression-free survival rate as compared with combined anterior-posterior approach.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chordoma; Lumbosacral; Meta-analysis; Onco-functional balance; Surgery; Survival

Year:  2022        PMID: 35182266     DOI: 10.1007/s10143-022-01745-z

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  13 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Authors:  Debraj Mukherjee; Kaisorn L Chaichana; Ziya L Gokaslan; Oran Aaronson; Joseph S Cheng; Matthew J McGirt
Journal:  J Neurosurg Spine       Date:  2010-12-24

3.  Operative management of sacral chordoma.

Authors:  Bruno Fuchs; Ian D Dickey; Michael J Yaszemski; Carrie Y Inwards; Franklin H Sim
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

4.  Surgical Treatment of sacrococcygeal chordoma.

Authors:  T Ozaki; A Hillmann; W Winkelmann
Journal:  J Surg Oncol       Date:  1997-04       Impact factor: 3.454

Review 5.  A review of the surgical management of sacral chordoma.

Authors:  B Kayani; S A Hanna; M D Sewell; A Saifuddin; S Molloy; T W R Briggs
Journal:  Eur J Surg Oncol       Date:  2014-04-25       Impact factor: 4.424

6.  Sacral chordoma: can local recurrence after sacrectomy be predicted?

Authors:  S A Hanna; W J S Aston; T W R Briggs; S R Cannon; A Saifuddin
Journal:  Clin Orthop Relat Res       Date:  2008-06-27       Impact factor: 4.176

7.  Management of sacrococcygeal chordomas.

Authors:  H Atalar; H Selek; Y Yildiz; Y Sağlik
Journal:  Int Orthop       Date:  2006-03-22       Impact factor: 3.075

8.  Long-term outcome following surgical treatment of sacral chordoma.

Authors:  Shunzo Osaka; Eiji Osaka; Toshio Kojima; Yukihiro Yoshida; Yasuaki Tokuhashi
Journal:  J Surg Oncol       Date:  2013-11-19       Impact factor: 3.454

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  The unresolved case of sacral chordoma: from misdiagnosis to challenging surgery and medical therapy resistance.

Authors:  Fabio Garofalo; Dimitrios Christoforidis; Pietro G di Summa; Béatrice Gay; Stéphane Cherix; Wassim Raffoul; Nicolas Demartines; Maurice Matter
Journal:  Ann Coloproctol       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.